Join
Live feed
·
INSIDERFilingvia Quantisnow
Catalyst Pharmaceuticals Inc. logo

Chief Strategy Officer Sundaram Preethi sold $103,649 worth of shares (3,924 units at $26.41), decreasing direct ownership by 9% to 41,081 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CPRX· Catalyst Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPRX (Catalyst Pharmaceuticals Inc.) and more on Quantisnow.